Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.


GREY:TBPMQ - Post by User

Comment by aYozzzon Aug 23, 2021 8:49pm
165 Views
Post# 33753041

RE:RE:RE:RE:RE:RE:People selling taking profits today that bought in.17 to .22

RE:RE:RE:RE:RE:RE:People selling taking profits today that bought in.17 to .22Canada is a fraction of the size of the USA, will syqe be sold in the USA by prescription? Are you guys FDA approved? Asking for a friend. You'll make a few mil a year in Canada. Tetra will handle the billions a year in US/global ;)
SamV21 wrote: Correction Tetra is not making the inhaler , once again misled by the promotional videos

The CAUMZ Kit is comprised of two constituents:  Tetra’s lead drug CAUMZ and the Mighty Medic device of Storz & Bickel, a wholly owned subsidiary of Canopy Growth.Tetra has a co-development agreement with Canopy Growth Corporation, which originally was Storz & Bickel prior to its acquisition by Canopy. The Mighty Medic is not available in the U.S. as a medical device.( statement from Tetras play book)
They sure make it sound like they developed the device in their promo material though.Its still ugly looks like a breathalyzer campared to the Syqe device inhaler for pain that has health Canada approval already and will be making revenue soon.


<< Previous
Bullboard Posts
Next >>